Irinotecan hydrochloride (Camptosar)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Irinotecan hydrochloride (Camptosar), covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer [Phase 4]